VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Technology Scientific & Technical Instruments

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by KILOFINALon Oct 29, 2020 11:09am

62 Views

Post# 31803191

RE:RE:RE:RE:The question becomes?

If 1 machine can theoretically do 100 patients a week at roughly 15 minutes per procedure, that's potentially $240,000 in revenue per year from just 1 machine

KILOFINAL wrote: I'm interested in the recurring revenue potential as VPT could generate $ from each procedure, $50 I believe was a number mentioned related to leasing/renting the equipment

Bullboard Posts

Canada Nickel unveils second of seven resources planned by mid-2025